Role of F-18 FDG PET/CT in assessment of initial staging and tumor response in pediatric non hodgkin lymphoma / Ahmed Elhussein Elsaid ; Supervised Mohamed Hany Hussein , Mohamed Fawzy Ibrahim , Walid Mohamed Omar
Material type: TextLanguage: English Publication details: Cairo : Ahmed Elhussein Elsaid , 2018Description: 182 P. : charts , facsimiles ; 25cmOther title:- دور أشعة التصوير الطبقي بالبوزيترون المنبعث المدمج مع الأشعة المقطعية فى تشخيص مدى الأنتشار و مدى أستجابة العلاج فى الأطفال المصابين بسرطان الغدد الليمفاوية اللاهودجكين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.05.Ph.D.2018.Ah.R (Browse shelf(Opens below)) | Not for loan | 01010110078397000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.05.Ph.D.2018.Ah.R (Browse shelf(Opens below)) | 78397.CD | Not for loan | 01020110078397000 |
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology
Background Pediatric Non Hodgkin lymphoma (NHL) is a heterogeneous disease with varied FDG uptake according to its histologic subtypes. Fluorine-18- fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and PET integration with computed tomography (PET/CT) combines a PET scanner detector with a helical CT multi-detector that enables precise localization of abnormal lesions and offers more sensitive and specific imaging than either modality alone. Patients and methods: This prospective study included 145 newly diagnosed NHL patients with the main four NHL histologic subtypes (Burkitt lymphoma [BL], Diffuse lymphoma, [DLBCL], Anaplastic large cell lymphoma [ALTCL] and Lymphoblastic lymphoma [LL]) treated at the Children Cancer Hospital Egypt (CCHE) and the National Cancer Institute (NCI), Cairo University during the period from October 2014 to October 2016 and patients were followed up till the end of April 2017
Issued also as CD
There are no comments on this title.